Results 41 to 50 of about 955 (158)

PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance

open access: yesBlood, 2014
Key PointsMyeloma cells are highly sensitive to PRIMA-1Met, independent of p53. PRIMA-1Met induces myeloma cell death by impairing GSH/ROS balance.
Tessoulin, Benoît   +10 more
openaire   +4 more sources

Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53 [PDF]

open access: yes, 2022
The TP53 tumor suppressor is mutated in ~75% of pancreatic cancers. The mutant TP53 protein in pancreatic ductal adenocarcinomas (PDAC) promotes tumor growth and metastasis.
Abrams S. L.   +13 more
core   +1 more source

Recent discoveries in the cycling, growing and aging of the p53 field [PDF]

open access: yes, 2012
The P53 gene and it product p53 protein is the most studied tumor suppressor, which was considered as oncogene for two decades until 1990. More than 60 thousand papers on the topic of p53 has been abstracted in Pubmed.
Demidenko, Zoya N., McCubrey, James A.
core   +2 more sources

PRIMA-1met Induces Autophagy in Colorectal Cancer Cells With Different p53 Status

open access: yes, 2020
Abstract Background: PRIMA-1met (APR246), a methylated form of PRIMA-1 (p53-reactivation and induction of massive apoptosis-1, APR-017), targets mutant p53 for restoring its wild-type structure and function. We previously demonstrated that PRIMA-1met was efficient in suppressing the growth of colorectal cancer (CRC) cells in a p53-independent ...
Xiao-lan Li   +4 more
openaire   +1 more source

Mutant p53–Nrf2 axis regulates the proteasome machinery in cancer

open access: yesMolecular & Cellular Oncology, 2017
The proteasome machinery is a common target of gain-of-function p53 missense mutants. Upregulation of the proteasome fosters chemoresistance to proteasome inhibitors.
Kamil Lisek   +2 more
doaj   +1 more source

A structure-guided molecular chaperone approach for restoring the transcriptional activity of the p53 cancer mutant Y220C [PDF]

open access: yes, 2019
Aim: The p53 cancer mutation Y220C creates a conformationally unstable protein with a unique elongated surface crevice that can be targeted by molecular chaperones.
Bauer, Matthias   +9 more
core   +1 more source

An Engineered Escherichia coli Strain with Synthetic Metabolism for in‐Cell Production of Translationally Active Methionine Derivatives

open access: yesChemBioChem, Volume 21, Issue 24, Page 3525-3538, December 11, 2020., 2020
Doing things differently: We have metabolically engineered an E. coli strain by reconfiguring the methionine biosynthetic pathway to create a bacterial system with a trans‐sulfuration pathway for in‐cell production and incorporation of l‐azidohomoalanine.
Christian Johannes Schipp   +7 more
wiley   +1 more source

Recent progress in genetics of aging, senescence and longevity: focusing on cancer-related genes [PDF]

open access: yes, 2012
It is widely believed that aging results from the accumulation of molecular damage, including damage of DNA and mitochondria and accumulation of molecular garbage both inside and outside of the cell.
Abate-Shen   +229 more
core   +2 more sources

Modulation of p53's transcriptional function by small molecules [PDF]

open access: yes, 2011
p53 tumour suppressor is a transcriptional factor which induces apoptosis or growth arrest in response to stress thus eliminating damaged cells. p53 function is frequently abrogated in tumours either via inactivation mutations in the TP53 gene or by ...
Nikulenkov, Fedor
core   +1 more source

Inhibiting system xC− and glutathione biosynthesis – a potential Achilles' heel in mutant-p53 cancers

open access: yesMolecular & Cellular Oncology, 2017
Effective therapeutic strategies to target mutant tumor protein p53 (TP53, best known as p53) cancers remain an unmet medical need. We found that mutant p53 impairs the function of nuclear factor (erythroid-derived 2)-like 2 (NFE2L2, commonly known as ...
Nicholas J. Clemons   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy